Webinar | Intra-Aortic Balloon Pumps (IABP)| December 22, 2015

Webinar: Hemodynamics of Counterpulsation

This webinar is sponsored by Maquet

IABP

The webinar "Hemodynamics of Counterpulsation" explained how the intra-aortic balloon pump (IABP) can increase diastolic aortic pressure and augment coronary blood flow and reduce aortic and left ventricular systolic pressure or afterload. This education offering provides a review of the physiologic benefits, evaluation of patient response, discusses how patients may derive the most benefit and offers practical technical components to optimize IABP therapy.


The live webinar was Jan. 28, 2016, but a recorded version is available on demand.  
Register for the on demand webinar


Statement of Purpose/Need: 

The Intra-aortic balloon pump (IABP) has been the first-line choice for mechanical circulatory support around the world due to its clinical efficacy, safety profile across a broad range of patient care scenarios, and low cost. IABP therapy is the most widely used nondurable mechanical circulatory support device (MCS), with more than 160,000 IAB catheters placed globally per a year. The primary goals of the IABP are to (1) increase diastolic aortic pressure and augment coronary blood flow, and (2) reduce aortic and left ventricular systolic pressure or afterload. This education offering will provide a review of the physiologic benefits, evaluate patient response, discuss what patients may derive the most benefit and practical technical components to optimize IABP therapy.


After completing the webinar, the participant should be able to::


• Assess the physiologic effects of Intra-aortic balloon counterpulsation (IABP) therapy

• Understand the clinical utility of IAB use

• Describe the factors that effect IAB catheter performance and benefits of larger-capacity IAB catheters


Speaker:



Atman P. Shah 

Associate Professor of Medicine 

Clinical Director, Section of Cardiology 

Co-Director, Cardiac Catheterization Laboratory


Atman P. Shah, M.D., is an interventional cardiologist at the University of Chicago. Shah's research efforts focus on improving survival rates in patients who have experienced a cardiac arrest or an acute myocardial infarction (heart attack). Additionally, he studies new therapies that can help save heart muscle during a heart attack. Shah is the primary investigator on a number of large multicenter clinical trials investigating novel medications and devices designed to improve the quality of life in patients with coronary artery and structural heart disease. Shah has authored six book chapters and more than 50 abstracts and publications. A dedicated educator, he trains medical students, residents and fellows. He is the recipient of several honors and awards for clinical service, leadership and teaching.


About Maquet Medical Systems

Since 1838, the Maquet brand has been synonymous with high-quality products for patient-focused care. Maquet is a global leader in medical systems that advance surgical interventions, cardiovascular procedures and critical care. Cardiovascular specialties include intra-aortic balloon counterpulsation therapy for cardiac assist; coronary artery bypass surgery; aortic and peripheral vascular surgery; and extracorporeal circulation. Maquet continuously strives to develop innovative technologies that enhance clinical expertise and improve healthcare economics, while also enabling medical professionals to achieve the best possible outcomes for all patients.


For more information please visit www.maquet.com



Register for the on demand webinar


Related Content

Feature | Inventory Management| April 28, 2017 | Dave Fornell
Tracking cardiovascular device inventory in cath labs, electrophysiology (EP) labs and operating rooms (ORs) can be a
the Impella pVAD improves survival, mortality in AMI heart attack with cardiogenic shock
Feature | Hemodynamic Support Devices| April 28, 2017 | Dave Fornell
Recent clinical study data presented at the American College of Cardiology (ACC) 2017 meeting show new treatment prot
New Twelve-Month Data Show Efficacy of Pulsar-18 Bare Metal Stent
News | Stents Peripheral| April 28, 2017
Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world setting, according to the...
New Hampshire Hospital Expands Vascular Care with Toshiba Medical's Infinix-I Sky +
News | Angiography| April 27, 2017
Wentworth-Douglass Hospital in Dover, N.H., installed Toshiba Medical’s Infinix-i Sky + angiography system in its...
Mercator MedSystems Announces First Enrollment in TANGO Trial for Below-the-Knee Vascular Disease
News | Peripheral Arterial Disease (PAD)| April 27, 2017
Mercator MedSystems Inc. announced the first patient enrollment into the TANGO (Temsirolimus Adventitial Delivery to...
News | Venous Therapies| April 26, 2017
A new Varicose Vein Registry has begun producing useful outcomes information, as reported in the May edition of the...
Twelve-Month Data Positive for Ranger Paclitaxel-Coated Balloon Catheter
News | Drug-Eluting Balloons| April 26, 2017
Boston Scientific announced results from the RANGER SFA trial for the Ranger Paclitaxel-Coated PTA Balloon Catheter at...
CSI recall for saline pump on its atherectomy system
News | Atherectomy Devices| April 19, 2017
Cardiovascular Systems Inc. (CSI) announced April 18 it had initiated a voluntary recall of its 7-10014 Saline Infusion...
Louisiana Medical Center Installs First U.S. Toshiba Medical Infinix-i Sky +
News | Angiography| April 18, 2017
April 18, 2017 — Patients at Terrebonne General Medical Center (TGMC) in Houma, La., now have access to safe, high-qu
Overlay Init